AI allows individualized predictions for expectant mothers and newborn children. The aim of the individual recommendations is a positive experience for the user combined with activity that is beneficial for the glucose level.
About 52,000 women give birth in Finland every year, and 18 per cent of them – nearly 10,000 – are diagnosed with gestational diabetes. Of these, roughly half develop type 2 diabetes later on.
CleverHealth Network, an ecosystem coordinated by the Hospital District of Helsinki and Uusimaa (HUS), is now launching its first development project with funding granted by Business Finland. The main partners in the gestational diabetes project are HUS, Aalto University, the University of Helsinki, Elisa and Fujitsu. The project is run by FCAI researchers Pekka Marttinen ja Giulio Jacucci.
The project aims to improve the treatment and monitoring of gestational diabetes by developing a mobile application for measuring the mother’s blood glucose levels, physical activity, nutrition, pulse and daily weight and storing it in the cloud in real time.